Back

Prodromal manifestations of Parkinson's disease in adults with 22q11.2 microdeletion syndrome

Juri, C.; Chana, P. M.; Kramer, V.; Fritsch, R.; Ornstein, C.; Cuiza, A.; Hernandez, C.; Villanueva, K.; Cordova, T.; Mauro, J.; Ocampo, A.; Rebolledo-Jaramillo, B.; Encina, G.; Calleja, A.; Alcayaga, J. P.; Dinator, J.; Crossley, N.; Repetto, G. M.

2022-05-20 genetic and genomic medicine
10.1101/2022.05.18.22275282 medRxiv
Show abstract

22q11.2 microdeletion syndrome (22qDS) was recently identified as a risk factor for development of early-onset Parkinsons disease (PD). The classical motor manifestations of this disease are preceded by early signs and symptoms of neurodegeneration. The progression of 22qDS-associated PD is unknown. We aimed to evaluate the presence of prodromal PD in a group of adults with 22qDS using the Movement Disorders Society (MDS) Criteria for Prodromal PD. Thirty-eight persons with 22qDS and 13 age-matched controls participated in the study, and their results were compared using the Mann-Whitney U test. Persons with 22qDS had lower scores on olfaction testing (p=7.42Ex10-5), higher scores on the COMPASS 31 scale for dysautonomia (p=2.28x10-3) and on the motor evaluation using Movement Disorder Society (MDS)-sponsored revision of Unified Parkinsons Disease Rating Scale motor subscore (UPDRS-III) (p=1.84x10-4), compared with healthy controls. Home polysomnogram did not find participants with REM-sleep behavior disorder. Integrity of nigrostriatal dopaminergic system was evaluated by PET-CT imaging of presynaptic dopamine with 18F-PR04.MZ. Patients showed significantly higher specific binding ratios in the striatum, compared to controls (p=9.57x10-3 at the caudate nuclei). Two patients with 22qDS (5.2%) had decreased uptake in the posterior putamen (less than 60% of controls) and one fulfilled MDS criteria for prodromal PD. These results show that patients with 22qDS manifest some signs and symptoms of prodromal PD such as hyposmia, dysautonomia and mild movement alterations. In the majority, this was associated with elevated dopaminergic signaling, suggesting that loss of dopaminergic neurons may not be the cause. A smaller subgroup did show evidence of a decrease in nigrostriatal dopaminergic signaling, as seen in classical prodromal PD. Longitudinal studies are necessary to understand the progression to and risk of PD in persons with 22qDS.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Parkinsonism & Related Disorders
21 papers in training set
Top 0.1%
22.9%
2
Movement Disorders
62 papers in training set
Top 0.1%
14.9%
3
npj Parkinson's Disease
89 papers in training set
Top 0.3%
12.5%
50% of probability mass above
4
International Journal of Molecular Sciences
453 papers in training set
Top 2%
3.7%
5
Scientific Reports
3102 papers in training set
Top 35%
3.6%
6
Neurobiology of Aging
95 papers in training set
Top 0.8%
3.6%
7
Neurobiology of Disease
134 papers in training set
Top 1%
3.6%
8
Frontiers in Neuroscience
223 papers in training set
Top 2%
3.1%
9
Brain Communications
147 papers in training set
Top 0.9%
2.8%
10
PLOS ONE
4510 papers in training set
Top 47%
2.1%
11
Frontiers in Aging Neuroscience
67 papers in training set
Top 2%
1.9%
12
Journal of Neurology
26 papers in training set
Top 0.5%
1.8%
13
Frontiers in Neurology
91 papers in training set
Top 3%
1.7%
14
Journal of Parkinson's Disease
13 papers in training set
Top 0.3%
1.5%
15
Biomedicines
66 papers in training set
Top 2%
1.2%
16
Heart Rhythm
22 papers in training set
Top 0.5%
1.2%
17
Molecular Pharmaceutics
16 papers in training set
Top 0.5%
0.8%
18
Journal of Neurology, Neurosurgery & Psychiatry
29 papers in training set
Top 1%
0.8%
19
Annals of Neurology
57 papers in training set
Top 2%
0.8%
20
BMC Genomics
328 papers in training set
Top 6%
0.7%
21
Brain
154 papers in training set
Top 5%
0.7%
22
Cells
232 papers in training set
Top 8%
0.7%
23
Neurology Genetics
14 papers in training set
Top 0.4%
0.7%
24
BMJ Open
554 papers in training set
Top 14%
0.5%
25
Frontiers in Molecular Biosciences
100 papers in training set
Top 7%
0.5%
26
Brain and Behavior
37 papers in training set
Top 2%
0.5%
27
Molecular and Cellular Neuroscience
18 papers in training set
Top 0.9%
0.5%